Medical Technology in Russia: Between Dependence on Imports and the Pursuit of Self-Sufficiency
Since 2022, Russia has been striving for greater technological sovereignty in the healthcare sector. However, the import substitution of medical technology has been slow. Between 2022 and 2025, the market share of Russian devices rose only from 19% to 21%, according to an industry analysis by the Russian market research firm Techart. RT-Medizinskiji Technologii (RT-MedTech), a subsidiary of the state-owned Rostec corporation, estimates the market share of Russian devices at 32%. The government aims to increase this to 40% by 2030.
This ambitious goal will be difficult to achieve under the current challenging market conditions. Medical technology—with the exception of certain dual-use goods—is not subject to the general sanctions restrictions against Russia. However, the sanctions-induced rerouting of logistics routes has led to longer delivery times and higher procurement costs for Russia.
According to the Techart industry report, the medical technology market met 79% of its demand through imports in 2025. Techart notes that dependence on imports is particularly high for high-tech medical devices and complex diagnostic systems, such as computed tomography (CT) and magnetic resonance imaging (MRI) equipment. IMEDA, the association of international medical technology manufacturers, estimates that imports account for 80% of this technology category. Experts also note a high dependence on foreign components such as microchips, sensors, optics, and specialty materials.
According to Techart, the share of imports for operating room equipment exceeds 80%. Russian production primarily consists of dressing materials and devices such as medical monitors, irrigation and suction pumps, and operating room lights. In the in-vitro diagnostics segment—that is, the laboratory analysis of samples such as blood, urine, or tissue taken from the body—dependence is significantly lower, with an import share of 50%. Domestic manufacturers are catching up in the areas of consumables, laboratory technology, and basic diagnostic devices such as stethoscopes, blood pressure monitors, and pulse oximeters. Complex laboratory analyzers, on the other hand, continue to be sourced from abroad.
Surgical Equipment—Largest Segment
The medical technology market grew by 3% in 2025 to 876.6 billion rubles, equivalent to 9.3 billion euros. Over the past five years, the average growth rate was 5%. Growth drivers for the medical technology market included the modernization of equipment in medical facilities, demand for diagnostic and laboratory devices, and the rapid development of digital medical technologies. Last year, 68% of demand for medical technology came from public institutions and 32% from the private clinic sector.
The market research firm Techart estimates that the Russian medical technology market will reach 866 billion rubles by 2025, equivalent to 9.2 billion euros. Surgical equipment generated the greatest demand, accounting for 268.4 billion rubles (2.9 billion euros) in sales—a market share of 31%. This included medical devices for surgery and endoscopy, operating tables, surgical instruments, and surgical systems. Equipment and consumables for laboratory testing totaled 181.8 billion rubles, approximately 1.9 billion euros (21%); the orthopedic rehabilitation segment generated 121 billion rubles, 1.3 billion euros (14%), and medical imaging—95 billion rubles, 1.01 billion euros (11%). Other, unspecified medical devices accounted for 199 billion rubles, approximately 2.12 billion euros (23%).
The Russian medical technology (MedTech) market is diverse. In addition to medical technology proper, the market also includes the in-vitro diagnostics (IVD) and digital health segments—products for preventive healthcare and improving quality of life. These include medical software, IT solutions for the healthcare sector, mobile health applications, and telemedicine.
Russian Medical Technology Manufacturers
According to data from the Russian Ministry of Industry and Trade, approximately 3,000 companies were active in the medical technology sector in Russia in 2023. Only 180 billion rubles (1.91 billion euros) of the total medical technology market volume (866 billion rubles, 9.2 billion euros) came from Russian production in 2025, representing a 53.5% increase over the previous year.
The Ural-based medical technology company UPZ, which belongs to the Radioelektronnye Technologi Group and is part of the state-owned giant Rostec, manufactures anesthesia and ventilation devices as well as resuscitation equipment. The company generated 2.21 billion rubles in revenue last year (23.5 million euros). The Axion Group, based in the city of Izhevsk and founded in 1930, generated nearly the same amount in revenue. Axion, which specializes in radiation measurement devices and diagnostic technology, reported revenue of 2.20 billion rubles (23.4 million euros). The Ural-based company Treaton Electronics (ventilators and patient monitors) posted revenue of 1.8 billion rubles, equivalent to 19.1 million euros.
Dixion, a company based in Düsseldorf, has a broad international presence and also distributes its medical devices in Russia and the CIS countries. In 2025, the company sold medical technology in Russia worth 665.9 million rubles (7.08 million euros).
When it comes to equipment and consumables for laboratory testing, the Novosibirsk-based company Vector Best is the clear market leader (annual revenue of 8.5 billion rubles – 90.4 million euros). The company produces reagents and equipment for numerous areas of laboratory diagnostics. The Moscow-based company DNK Technologija also plays an important role in the laboratory segment and generated 5.5 billion rubles (58.5 million euros) in revenue last year. The leaders in the production of imaging devices were the Moscow-based companies MTL (2025 revenue: 6.1 billion rubles – 64.9 million euros) and Amico (3.25 billion rubles – 34.6 million euros), as well as Electron from St. Petersburg (3.19 billion rubles – 33.9 million euros).
Imported brands: seven out of ten devices
Last year, Russia imported medical technology worth 690 billion rubles (7.34 billion euros)—an increase of about 8% over the previous year. AnalitikaMed, a Moscow-based data provider for medical devices, analyzed government supply contracts for medical technology under Procurement Law No. 44 for the federal government and local authorities in 2025. The total value of the medical technology procured amounted to 129.2 billion rubles (1.37 billion euros). While these figures cover only a portion of the procurement volume, they indicate high demand for foreign medical technology. Of the ten listed manufacturer brands, seven are from abroad.
Mindray from China (3.5 billion rubles, approx. 37.2 million euros) supplied laboratory analyzers, patient monitors, and anesthesia machines. Philips from the Netherlands supplied X-ray machines (3.3 billion rubles – 35.1 million euros), while the U.S. company GE HealthCare supplied ultrasound and X-ray machines (2.6 billion rubles – 27.6 million euros). The statistics also include: the Swiss company Roche Diabetes (laboratory equipment, 2.5 billion rubles – 26.6 million euros), Olympus Medical Systems from Japan (endoscopic equipment, 1.9 billion rubles – 20.2 million euros), the British company SLE Limited (resuscitation equipment, 1.5 billion rubles – 16 million euros), and the German brand Karl Storz from Baden-Württemberg (endoscopy and laparoscopy equipment for minimally invasive surgical procedures, 1.4 billion rubles – 14.9 million euros).
“Made in Germany” Still in Demand
Report Service, a Russian data provider specializing in medical technology, has compiled statistics on imports from Russia’s largest medical technology suppliers. The focus was on shipments of high-tech equipment for computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound between 2018 and 2024.
The U.S. led the way in CT and MRI equipment. On average, the United States exported CT scanners worth 32.40 billion rubles (344.5 million euros) and MRI scanners worth approximately 36 billion rubles (382.8 million euros) to Russia. The figures from 2024 stand out in particular—41.9 billion rubles, 445.5 million euros (CT), and 49.6 billion rubles, 527.4 million euros (MRI). Germany accounted for the second-highest number of shipments: an average of 20.37 billion rubles (216.6 million euros) for CT scanners and 34.26 billion rubles (364.3 million euros) for MRI scanners. The third-largest supplier was the Netherlands: 16.94 billion rubles, 180.1 million euros (CT scanners), and 20.06 billion rubles, 213.3 million euros (MRI scanners).
The U.S. corporation General Electric supplied the most CT scanners, with a market share of about 42%. Siemens Healthineers ranked second with 13.8%, followed by the Dutch company Philips (13%) and the Japanese technology brands Canon and Hitachi (4.9%). The Chinese manufacturers Shenzhen Anke High-tech, Neusoft Medical, and MinFound Medical Systems combined for 11.2%.
In the ultrasound equipment sector, the U.S. also claimed the lead with an average import value of 28.4 billion rubles, followed by South Korea (14.60 billion rubles – 155.2 million euros) and China (14.56 billion rubles – 154.8 million euros). In general, it is evident that in recent years, Russia has also sourced medical technology from countries that were previously less relevant to this market—such as China and Belarus (CT scanners). The market research firm Delovoj Profil estimated that Chinese medical devices would account for 30% of total imports in 2024 and highlighted the Chinese device manufacturers Mindray, SonoScape, and Zoncare.
High Demand for Prosthetics
RT-MedTech reports the highest degree of localization in medical technology (74%) in the field of orthopedic rehabilitation. This segment includes, among other things, physical therapy devices, rehabilitation and training equipment, as well as prosthetics, orthotics, walkers, and wheelchairs. The government aims to increase production volume from 60.9 billion rubles in 2025 to 105.56 billion rubles in 2030, equivalent to 640 million to 1.1 billion euros. The market share of domestic medical devices in this sector is thus expected to grow from the current 52% to 64%. According to the auditing and consulting firm Technologiji Dowerija (TeDo), the market volume for orthopedic rehabilitation amounted to 145.4 billion rubles (1.55 billion euros) last year. TeDo forecasts a market volume of 506 billion rubles (5.3 billion euros) by 2030.
The Moscow-based Prosthetics and Orthopedics Company (Moskovskoye Protesnoe-Ortopedicheskoe Predpriyatiye) dominates this sector; in addition to prosthetics and orthotics, it also manufactures prosthetics for animals. Last year, the market leader generated 14.8 billion rubles (157 million euros). The Moscow-based company Zito (part of the state-owned Rostec Group), which specializes in endoprostheses (artificial joint replacements) as well as implants and bone plates, also plays an important role in this segment. Zito reported revenue of 4.5 billion rubles (48 million euros) last year. Elamed, based in the Ryazan region, which manufactures physical therapy equipment, among other products, generated 4 billion rubles in revenue last year (43 million euros).
According to TeDo, 13.7 million rehabilitation aids were sold last year—an increase of one million units. Leg prostheses accounted for the largest share of sales (30%), followed by orthopedic aids such as orthoses (21%) and wheelchairs (12%).
At the same time, analysts estimate the market demand for rehabilitation aids at 36 million units today. By the end of the decade, demand could rise to 42 million units. Experts attribute this to the fact that a single person may use multiple prostheses for different purposes (daily life, running, swimming) and that prostheses must be replaced after a certain period of time due to wear and tear.
According to the Russian Ministry of Health, 1.5 million people are provided with rehabilitation aids annually, of whom 200,000 have prostheses. The state-owned corporation Rostec puts the number of people with amputations in Russia at 500,000. “About 60–70% of amputations are related to vascular diseases,” Rostec reports. The average age of these patients is over 60. “The proportion of young people requiring prosthetics was about 8% until 2022; it now stands at 15–20%. These are primarily military personnel who were wounded in the conflict in Ukraine,” explains Rostec.
Source: German-Russian Chamber of Foreign Trade, Medical Technology in Russia: Between Import Dependence and the Pursuit of Sovereignty, October 12, 2026.
This article was prepared for the German-Russian Chamber of Foreign Trade.